The James Fund for Neuroblastoma Research

The James Fund for Neuroblastoma Research

June 15, 2012 08:47 ET

Media Advisory: Descending on Toronto are World's Top Scientists Researching One of Deadliest Cancers

The James Fund sponsors prestigious international "think tank" dedicated to fighting one of the most common of deadly childhood cancers

TORONTO, ONTARIO--(Marketwire - June 15, 2012) -

Attention News/Photo/Health Editors

Toronto is going to be a whole lot smarter from June 18-21 when some of the brightest minds racing to save children from neuroblastoma, the most deadly of childhood cancers, will come together to share their latest findings. The Advances in Neuroblastoma Research is the premier gathering among investigators from around the globe who are studying neuroblastoma biology, diagnosis, prognosis, and therapy.

The James Fund for Neuroblastoma Research, a family fund, is the Diamond Sponsor for this year's conference.

What: ANR is the international symposium dedicated to preclinical and clinical research in neuroblastoma. ANR meetings are held every two years at different international cities. This will be one of the major international events in paediatric oncology in 2012 and will bring together 500 neuroblastoma delegates from around the world.
For the first time in its history, the conference will include a Parent Symposium with roundtable discussions of importance to neuroblastoma parents led by industry experts. The James Fund is also sponsoring a Parent Reception immediately following the Parent Symposium. This gathering will provide an opportunity for neuroblastoma families to empower themselves by networking together, sharing their journeys, and brainstorming opportunities. Families from Holland, Australia, the USA, and the UK will be attending the parent sessions.
When: June 18-21, 2012
Where: Fairmont Royal York Hotel, 100 Front Street, West, Toronto, Ontario
Who: Syd Birrell, Founder of The James Fund and James' Dad.
Diana Birrell, Executive Director of The James Fund and James' Aunt.
Physicians, researchers, scientists, clinicians, nurses, social workers and allied health professionals coming from 32 different countries, as far away as Hong Kong, Norway, Mexico, and New Zealand.
James Fund neuroblastoma families who have been at the core of raising $4.9 Million through The James Fund.
Dr. Sylvain Baruchel is Chair of this year's ANR meeting.
Dr. David Kaplan is Senior Scientist, Hospital for Sick Children for The James Birrell Laboratories Investigators.
Dr. Meredith Irwin is Associate Chair, Research (Paediatrics), Hospital for Sick Children.

Neuroblastoma is statistically the deadliest of childhood cancers but is under funded by traditional granting agencies and pharmaceutical companies. The Peterborough community has rallied to take on this challenge and it is a point of civic pride that The James Fund has emerged as one of the leading funds in the world funding research into the disease.

More information:

About The James Fund for Neuroblastoma Research:

The James Fund was established by the family of James Birrell to generate funds and knowledge leading to new therapies for the treatment of patients with neuroblastoma. It has rapidly grown to be Canada's leading neuroblastoma research initiative and actor Tom Hanks is its Honorary Patron. To date, eighteen research projects have been funded, over twenty papers published, a drug-testing unit has been established, and eight international collaborations and a clinical trial are under way, bringing new hope to the parents of children suffering from this terrible childhood cancer.


Because scientific data being discussed is not yet ready for release, media is not permitted inside the conference.

Contact Information

  • For additional information and/or to arrange for
    an interview, please contact:
    The James Fund for Neuroblastoma Research
    Diana Birrell, Executive Director
    (705) 749-3941 (office) or (705) 927-5405 (cell) /